| Bioactivity | GPR41 agonist-1 (compound 9) is a potent GPR41 agonist. GPR41 agonist-1 can be used for researching insulin-related disorders[1]. | ||||||||||||
| Target | GPR41 | ||||||||||||
| Name | GPR41 agonist-1 | ||||||||||||
| CAS | 506417-09-0 | ||||||||||||
| Formula | C24H23N3O4 | ||||||||||||
| Molar Mass | 417.46 | ||||||||||||
| Appearance | Solid | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
||||||||||||
| Reference | [1]. James N. Leonard, et al. Gpr41 and modulators thereof for the treatment of insulin-related disorders. WO2006052566A2. |
GPR41 agonist-1
CAS: 506417-09-0 F: C24H23N3O4 W: 417.46
GPR41 agonist-1 (compound 9) is a potent GPR41 agonist. GPR41 agonist-1 can be used for researching insulin-related diso
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.